Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is currently the most promising biomarker for early detection of ischemia before the onset of irreversible cardiac injury. For its association with ischemia and low levels of oxygen, we suggested it as a marker of physiological hypoxia during placentation.
Ischemia modified albumin as a marker of physiological hypoxia during placentation
LIPPI, Giuseppe;SALVAGNO, GIAN LUCA;FRANCHI, Massimo Piergiuseppe;
2006-01-01
Abstract
Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is currently the most promising biomarker for early detection of ischemia before the onset of irreversible cardiac injury. For its association with ischemia and low levels of oxygen, we suggested it as a marker of physiological hypoxia during placentation.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
